{"id":6535,"date":"2020-06-09T16:00:00","date_gmt":"2020-06-09T16:00:00","guid":{"rendered":""},"modified":"2026-06-29T00:25:10","modified_gmt":"2026-06-29T00:25:10","slug":"con-un-76-de-pacientes-mejorando","status":"publish","type":"post","link":"https:\/\/entrepalabrasmxdigital.com\/?p=6535","title":{"rendered":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19"},"content":{"rendered":"<div style=\"-webkit-font-smoothing: antialiased; background-color: white; border: 0px; color: #757575; font-stretch: inherit; font-variant-east-asian: inherit; font-variant-numeric: inherit; line-height: inherit; margin: 0px; padding: 0px; text-align: justify; vertical-align: baseline;\">\n<ul>\n<li><em style=\"-webkit-font-smoothing: antialiased; color: black; font-variant-caps: inherit; font-variant-ligatures: inherit;\"><span style=\"font-family: Arial, Helvetica, sans-serif;\"><b>Resultados iniciales de los ensayos de la terapia experimental con plasma convaleciente del Hospital Houston Methodist<\/b><\/span><\/em><\/li>\n<\/ul>\n<\/div>\n<div style=\"-webkit-font-smoothing: antialiased; background-color: white; border: 0px; font-stretch: inherit; font-variant-east-asian: inherit; font-variant-numeric: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">\n<div style=\"text-align: justify;\">\n<span style=\"font-family: Arial, Helvetica, sans-serif;\"><br \/><\/span><\/div>\n<p><span style=\"color: #757575; font-family: Arial, Helvetica, sans-serif;\"><\/p>\n<div class=\"separator\" style=\"clear: both; text-align: center;\">\n<a href=\"https:\/\/blogger.googleusercontent.com\/img\/b\/R29vZ2xl\/AVvXsEhl9KyYTqgVWgKunVTNNjrPV68MJZ1GF2jxzeNcsbm1SghHcRBkmnoSre23xfolGTcsVlEnjp_cydjf9Z2djUGpO5XFXrZP4UTSaGQNlvcGp8pka-hxzrVuIk-kxu648W6gLDRuqKnuURw\/s1600\/COVID-19_webpage_1140x400.jpg\" imageanchor=\"1\" style=\"margin-left: 1em; margin-right: 1em;\"><img fetchpriority=\"high\" decoding=\"async\" border=\"0\" data-original-height=\"400\" data-original-width=\"1140\" height=\"140\" src=\"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg\" class=\"wp-image-6536\" width=\"400\" \/><\/a><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"color: black; font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\"><br \/><\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"color: black; font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\"><br \/><\/span><\/div>\n<div style=\"text-align: justify;\">\n<\/div>\n<div style=\"text-align: justify;\">\n<span style=\"color: black; font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Los primeros resultados en Estados Unidos con la aplicaci\u00f3n de la terapia de plasma convaleciente en pacientes con COVID-19 demostraron que 19 de 25 mejoraron tras recibir las transfusiones provenientes de personas recuperadas del virus; y 11 fueron ya dados de alta. El 28 de marzo, El Hospital Houston Methodist se convirti\u00f3 en el primer centro m\u00e9dico acad\u00e9mico, en los Estados Unidos, en transfundir plasma de pacientes recuperados de COVID-19 a dos pacientes cr\u00edticos inicialmente.<\/span><\/div>\n<p><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\"><\/p>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Sin efectos secundarios adversos encontrados, el estudio concluy\u00f3 que la transfusi\u00f3n de plasma convaleciente es una opci\u00f3n segura para pacientes con s\u00edntomas graves de COVID-19. Hasta la fecha, y a escala global, este ha sido el estudio cohorte m\u00e1s grande que se ha llevado a cabo para evaluar los resultados relacionados de esta terapia.<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">\u00abSi bien los cient\u00edficos m\u00e9dicos de todo el mundo trabajan en las pruebas de nuevos medicamentos y tratamientos contra el letal COVID-19, la terapia con suero convaleciente emerge como una de las estrategias m\u00e9dicas m\u00e1s prometedoras\u00bb, dijo el&nbsp;<\/span><a data-auth=\"Verified\" data-ogsc=\"rgb(0, 124, 137)\" href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftwitter.us12.list-manage.com%2Ftrack%2Fclick%3Fu%3Dccd393848c952c25bfd3afdd0%26id%3D3ef45d824b%26e%3D4429346d4d&amp;data=02%7C01%7C%7C9bea112180134449977708d7fc242899%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637255104532914956&amp;sdata=%2FBGt5Xgzlpj8pZo4EE1QD0%2F9OY%2FAX1CDYZWx%2BPGtSFk%3D&amp;reserved=0\" originalsrc=\"https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=3ef45d824b&amp;e=4429346d4d\" rel=\"noopener noreferrer\" shash=\"xfTMk4eIS\/mVIgohljN698BP3O51FPBMM12SGiDPMEnG77\/YoCf1Zw27pp5nhoviDd7cLRaO\/qnMQffdcHEjfRhiuAxCZWs7sexMSTS2VZeVAG3PNvxKlouqQEkQV5hkJakbPfT7XNTgGCLAcs57h4Y3\/qzW6c8i+xXhV6F1CRw=\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: #007c89; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\" target=\"_blank\" title=\"Protegido por Outlook: https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=3ef45d824b&amp;e=4429346d4d. Haz clic o pulsa para seguir el v\u00ednculo.\"><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">Doctor James M. Musser<\/span><\/a><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">, Jefe del Departamento de Patolog\u00eda y Medicina Gen\u00f3mica del Hospital Houston Methodist. \u00bb Al no tener a\u00fan cura o tratamientos efectivos comprobados contra el virus, tuvimos que actuar de manera r\u00e1pida y probar esta terapia\u201d. &nbsp;enfatiz\u00f3 el especialista.<\/span><\/div>\n<p><\/span><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\"><\/p>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Para el uso inicial de esta terapia, los pacientes fueron tratados bajo los lineamientos de emergencia de la Agencia de Medicamentos y Alimentaci\u00f3n de los Estados Unidos (La FDA por sus siglas en ingl\u00e9s). Posteriormente, la FDA aprob\u00f3 el 3 de abril que m\u00e1s pacientes fuesen tratados con la transfusi\u00f3n de plasma. Dicha aprobaci\u00f3n extraordinariamente r\u00e1pida por parte de la FDA, abri\u00f3 el acceso al tratamiento de plasma convaleciente, para pacientes con COVID-19.<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Esta terapia que se origin\u00f3 hace m\u00e1s de 100 a\u00f1os, permiti\u00f3 combatir la pandemia de gripe espa\u00f1ola en 1918. Incluso se utiliz\u00f3 con cierto \u00e9xito durante la pandemia del SARS en 2003, la pandemia de influenza H1N1 en 2009 y el brote de \u00e9bola en \u00c1frica del 2015. Despu\u00e9s de que muchos pacientes en China mostraron mejor\u00eda con esta terapia en un estudio temprano realizado en dicho pa\u00eds durante el inicio de la pandemia del COVID-19, un equipo multidisciplinario de cient\u00edficos m\u00e9dicos del Hospital Houston Methodist apunt\u00f3 r\u00e1pidamente a comenzar a combatir el COVID-19 con la terapia de suero convaleciente.<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">Dada la urgencia de encontrar tratamientos efectivos, se public\u00f3 un&nbsp;<\/span><a data-auth=\"Verified\" data-ogsc=\"rgb(0, 124, 137)\" href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftwitter.us12.list-manage.com%2Ftrack%2Fclick%3Fu%3Dccd393848c952c25bfd3afdd0%26id%3D6d6bfe3125%26e%3D4429346d4d&amp;data=02%7C01%7C%7C9bea112180134449977708d7fc242899%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637255104532924950&amp;sdata=I088wYe9aGbYhkUgeWKptNaGxeaj7YHsNYGMQ5ssDck%3D&amp;reserved=0\" originalsrc=\"https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=6d6bfe3125&amp;e=4429346d4d\" rel=\"noopener noreferrer\" shash=\"nqzLqHnjF1WWpciY7GW21jMmSBaqyel8UdTU5OgKDvl5pIDCcjPbhSSgMwpY42+MMogxBNWUhVMo50ijkpKVPPeLLZ98+gAOQK8l3JO+IsKAEng8pqcn0NdAAsD2ljfkvXyISZW3lGvMsreHSTxuBIyADRFxeLRrmxHBsAec9DU=\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: #007c89; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\" target=\"_blank\" title=\"Protegido por Outlook: https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=6d6bfe3125&amp;e=4429346d4d. Haz clic o pulsa para seguir el v\u00ednculo.\"><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">informe preliminar<\/span><\/a><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">&nbsp;en el servidor m\u00e9dico de consulta&nbsp;<\/span><a data-auth=\"Verified\" data-ogsc=\"rgb(0, 124, 137)\" href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftwitter.us12.list-manage.com%2Ftrack%2Fclick%3Fu%3Dccd393848c952c25bfd3afdd0%26id%3Dbefe93b220%26e%3D4429346d4d&amp;data=02%7C01%7C%7C9bea112180134449977708d7fc242899%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637255104532924950&amp;sdata=hYoYadTAH8LB52mNUsKOA1i5BRu2ttKl7O4yreBTQdA%3D&amp;reserved=0\" originalsrc=\"https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=befe93b220&amp;e=4429346d4d\" rel=\"noopener noreferrer\" shash=\"To+ABryaPt8Agm93mQ\/kY05LqgEROSGgCCWZJ0TLMtXhGvif0pwelwSPLHnacMO7FAiOzGM1VM6aqahyD\/\/QgpUjzF5M0z3hy0eFrRFnVRXHc\/5zyorQKFzYumDh84zSHYWrdIkRP11\/14qeBhgpJArUsFjMGavNizltRjSLems=\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: #007c89; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\" target=\"_blank\" title=\"Protegido por Outlook: https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=befe93b220&amp;e=4429346d4d. Haz clic o pulsa para seguir el v\u00ednculo.\"><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">medRxiv<\/span><\/a><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">, que a\u00fan no ha sido revisado por otros investigadores colegas m\u00e9dicos. El manuscrito se titula \u00abTratamiento de plasma convaleciente para pacientes con COVID-19 en Houston, Texas\u00bb. Dicho informe se envi\u00f3 para su revisi\u00f3n a una destacada revista m\u00e9dica, aunque no se trate aun de la versi\u00f3n final.<\/span><\/div>\n<p><\/span><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\"><\/p>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">El doctor Musser es el autor del estudio. Por su parte, el&nbsp;<\/span><a data-auth=\"Verified\" data-ogsc=\"rgb(0, 124, 137)\" href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftwitter.us12.list-manage.com%2Ftrack%2Fclick%3Fu%3Dccd393848c952c25bfd3afdd0%26id%3D5d3055c9ef%26e%3D4429346d4d&amp;data=02%7C01%7C%7C9bea112180134449977708d7fc242899%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637255104532924950&amp;sdata=OIc4ztSE2GUHZJNJVug8XkdfL25EQmIVdZBR6qPk47w%3D&amp;reserved=0\" originalsrc=\"https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=5d3055c9ef&amp;e=4429346d4d\" rel=\"noopener noreferrer\" shash=\"C+8JhvFdAvGMjO9rqJmgzm\/DLzd0OJzPRgcShpG1v+pOroKsQl4pWWEd\/xUerUaJg5AmZqKNIb9709VaX5zJhnxAq8kP6PjWhJHABEZ2Xg2jsZ4Hfjojs14N93AZMOtjmocJP5tbBgCDDqmYX6LD6u3vOOeiDDrhydXTCJME8R0=\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: #007c89; font-stretch: inherit; font-style: inherit; font-variant: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\" target=\"_blank\" title=\"Protegido por Outlook: https:\/\/twitter.us12.list-manage.com\/track\/click?u=ccd393848c952c25bfd3afdd0&amp;id=5d3055c9ef&amp;e=4429346d4d. Haz clic o pulsa para seguir el v\u00ednculo.\"><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">Doctor Eric Salazar<\/span><\/a><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\">, Profesor Asistente de Patolog\u00eda y Medicina Gen\u00f3mica del Instituto de Investigaci\u00f3n del Hospital Houston Methodist, es el investigador principal que dirigi\u00f3 el proyecto para tratar a pacientes cr\u00edticos con COVID-19 mediante plasma convaleciente de personas recuperadas.<\/span><\/div>\n<p><\/span><span data-ogsc=\"rgb(0, 0, 0)\" style=\"-webkit-font-smoothing: antialiased; border: 0px; color: black; font-stretch: inherit; font-style: inherit; font-variant: inherit; font-weight: inherit; line-height: inherit; margin: 0px; padding: 0px; vertical-align: baseline;\"><\/p>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Estos resultados fueron muy similares a los obtenidos recientemente en el estudio de uso compasivo del antiviral Remdesivir para ayudar a tratar el COVID-19. Tambi\u00e9n se concluy\u00f3 que cualquier complicaci\u00f3n observada estaba relacionada con los eventos reportados en la progresi\u00f3n del mismo COVID-19, y no provocados por las transfusiones de plasma. Los hallazgos generales fueron consistentes con varios otros estudios breves, tambi\u00e9n enfocados al uso de plasma convaleciente en pacientes cr\u00edticos, reportados recientemente.<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">Aunque la terapia de plasma convaleciente administrada en el Hospital Houston Methodist se implement\u00f3 bajo esquemas de tratamiento de emergencia, los autores del estudio consideran importante que se determine su eficacia terap\u00e9utica, a trav\u00e9s de ensayos cl\u00ednicos controlados. Actualmente se est\u00e1 considerando un estudio aleatorio controlado donde se analizar\u00edan variables como la aplicaci\u00f3n de la transfusi\u00f3n despu\u00e9s del inicio de los s\u00edntomas, el n\u00famero y volumen de transfusiones seg\u00fan la biometr\u00eda del paciente, los niveles de anticuerpos en el plasma del donante y muchos par\u00e1metros necesarios para evaluar efectivamente c\u00f3mo optimizar esta terapia. Esto ayudar\u00eda a resolver dudas como por ejemplo saber si los pacientes tendr\u00edan mejores resultados si las transfusiones de plasma se administraran al iniciar los s\u00edntomas.<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">&nbsp;<\/span><\/div>\n<div style=\"text-align: justify;\">\n<span style=\"font-style: inherit; font-variant-caps: inherit; font-variant-ligatures: inherit; font-weight: inherit;\">No todos los receptores de plasma convaleciente en Houston Methodist, hasta ahora, fueron parte de este primer ensayo. Desde finales de marzo, cuando se hicieron las primeras transfusiones, se han tratado 70 pacientes con COVID-19 en estado cr\u00edtico, y al menos 30 han sido dados de alta y se est\u00e1n recuperando. M\u00e1s de 150 personas recuperadas del COVID-19 donaron su plasma, y \u200b\u200bmuchas de ellas continuaron haci\u00e9ndolo con frecuencia.<\/span><\/div>\n<p><\/span><\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Resultados iniciales de los ensayos de la terapia experimental con plasma convaleciente del Hospital Houston Methodist Los primeros resultados en Estados Unidos con la aplicaci\u00f3n de la terapia de plasma convaleciente en pacientes con COVID-19 demostraron que 19 de 25 mejoraron tras recibir las transfusiones provenientes de personas recuperadas del virus; y 11 fueron ya [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":6536,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[359,1194,922,1195,1196,46,1197,1198],"class_list":["post-6535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-covid-19","tag-hospital","tag-houston","tag-mejora","tag-methodist","tag-pacientes","tag-plasma","tag-terapia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/entrepalabrasmxdigital.com\/?p=6535\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras\" \/>\n<meta property=\"og:description\" content=\"Resultados iniciales de los ensayos de la terapia experimental con plasma convaleciente del Hospital Houston Methodist Los primeros resultados en Estados Unidos con la aplicaci\u00f3n de la terapia de plasma convaleciente en pacientes con COVID-19 demostraron que 19 de 25 mejoraron tras recibir las transfusiones provenientes de personas recuperadas del virus; y 11 fueron ya [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/entrepalabrasmxdigital.com\/?p=6535\" \/>\n<meta property=\"og:site_name\" content=\"EntrePalabras\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-09T16:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T00:25:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"141\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"entrepalabras\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"entrepalabras\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535\"},\"author\":{\"name\":\"entrepalabras\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/#\\\/schema\\\/person\\\/7e4adbd71849efdae7f005d1c49eb0b5\"},\"headline\":\"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19\",\"datePublished\":\"2020-06-09T16:00:00+00:00\",\"dateModified\":\"2026-06-29T00:25:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535\"},\"wordCount\":860,\"image\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/COVID-19_webpage_1140x400.jpg\",\"keywords\":[\"#COVID-19\",\"#hospital\",\"#Houston\",\"#mejora\",\"#Methodist\",\"#pacientes\",\"#plasma\",\"#terapia\"],\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535\",\"url\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535\",\"name\":\"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/COVID-19_webpage_1140x400.jpg\",\"datePublished\":\"2020-06-09T16:00:00+00:00\",\"dateModified\":\"2026-06-29T00:25:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/#\\\/schema\\\/person\\\/7e4adbd71849efdae7f005d1c49eb0b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#primaryimage\",\"url\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/COVID-19_webpage_1140x400.jpg\",\"contentUrl\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/COVID-19_webpage_1140x400.jpg\",\"width\":400,\"height\":141},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?p=6535#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/#website\",\"url\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/\",\"name\":\"EntrePalabras\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/#\\\/schema\\\/person\\\/7e4adbd71849efdae7f005d1c49eb0b5\",\"name\":\"entrepalabras\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/?s=96&d=mm&r=g\",\"caption\":\"entrepalabras\"},\"url\":\"https:\\\/\\\/entrepalabrasmxdigital.com\\\/?author=2\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/entrepalabrasmxdigital.com\/?p=6535","og_locale":"es_ES","og_type":"article","og_title":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras","og_description":"Resultados iniciales de los ensayos de la terapia experimental con plasma convaleciente del Hospital Houston Methodist Los primeros resultados en Estados Unidos con la aplicaci\u00f3n de la terapia de plasma convaleciente en pacientes con COVID-19 demostraron que 19 de 25 mejoraron tras recibir las transfusiones provenientes de personas recuperadas del virus; y 11 fueron ya [&hellip;]","og_url":"https:\/\/entrepalabrasmxdigital.com\/?p=6535","og_site_name":"EntrePalabras","article_published_time":"2020-06-09T16:00:00+00:00","article_modified_time":"2026-06-29T00:25:10+00:00","og_image":[{"width":400,"height":141,"url":"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg","type":"image\/jpeg"}],"author":"entrepalabras","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"entrepalabras","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#article","isPartOf":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535"},"author":{"name":"entrepalabras","@id":"https:\/\/entrepalabrasmxdigital.com\/#\/schema\/person\/7e4adbd71849efdae7f005d1c49eb0b5"},"headline":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19","datePublished":"2020-06-09T16:00:00+00:00","dateModified":"2026-06-29T00:25:10+00:00","mainEntityOfPage":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535"},"wordCount":860,"image":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#primaryimage"},"thumbnailUrl":"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg","keywords":["#COVID-19","#hospital","#Houston","#mejora","#Methodist","#pacientes","#plasma","#terapia"],"articleSection":["Uncategorized"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535","url":"https:\/\/entrepalabrasmxdigital.com\/?p=6535","name":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19 - EntrePalabras","isPartOf":{"@id":"https:\/\/entrepalabrasmxdigital.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#primaryimage"},"image":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#primaryimage"},"thumbnailUrl":"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg","datePublished":"2020-06-09T16:00:00+00:00","dateModified":"2026-06-29T00:25:10+00:00","author":{"@id":"https:\/\/entrepalabrasmxdigital.com\/#\/schema\/person\/7e4adbd71849efdae7f005d1c49eb0b5"},"breadcrumb":{"@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/entrepalabrasmxdigital.com\/?p=6535"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#primaryimage","url":"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg","contentUrl":"https:\/\/entrepalabrasmxdigital.com\/wp-content\/uploads\/2020\/06\/COVID-19_webpage_1140x400.jpg","width":400,"height":141},{"@type":"BreadcrumbList","@id":"https:\/\/entrepalabrasmxdigital.com\/?p=6535#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/entrepalabrasmxdigital.com\/"},{"@type":"ListItem","position":2,"name":"Con un 76% de pacientes mejorando, estudio demuestra seguridad en la terapia de plasma contra el COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/entrepalabrasmxdigital.com\/#website","url":"https:\/\/entrepalabrasmxdigital.com\/","name":"EntrePalabras","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/entrepalabrasmxdigital.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/entrepalabrasmxdigital.com\/#\/schema\/person\/7e4adbd71849efdae7f005d1c49eb0b5","name":"entrepalabras","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","caption":"entrepalabras"},"url":"https:\/\/entrepalabrasmxdigital.com\/?author=2"}]}},"_links":{"self":[{"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/posts\/6535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6535"}],"version-history":[{"count":1,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/posts\/6535\/revisions"}],"predecessor-version":[{"id":6537,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/posts\/6535\/revisions\/6537"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=\/wp\/v2\/media\/6536"}],"wp:attachment":[{"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entrepalabrasmxdigital.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}